Cited by 202Neuroendocrine regulation and behaviorAutism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Can oxytocin treat autism?

Open access
Young, Larry J., Barrett, Catherine E.·2015·Science

Abstract

We are still at an early stage of assessing oxytocin-based therapy for autism spectrum disorders

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.aaa8120

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These alternate means of manipulating the OT system, if used in humans, could potentially increase the effect size to levels similar to central injections of OT.

    “These alternate means of manipulating the OT system, if used in humans, could potentially increase the effect size to levels similar to central injections of OT (36).”

    From Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies (2016) · cites this paper as [36]

    In “Can oxytocin treat autism?” (page unavailable), Young suggests that alternative approaches to the oxytocin system may overcome limitations of current therapies and improve social cognition; a DREADD approach might one day be feasible in humans. The paper does not discuss effect sizes or predict effects comparable to central oxytocin injections. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Understanding the precise neural and cognitive effects of OT manipulation on the processing of social information can be used to increase the efficacy of OT-based therapies to improve social function in psychiatric disorders.

    “Understanding the precise neural and cognitive effects of OT manipulation on the processing of social information can be used to increase the efficacy of OT-based therapies to improve social function in psychiatric disorders (36).”
  • For oxytocin administration to be therapeutic and influence behaviour, it must be paired with an appropriate social context.

    “for oxytocin administration to be therapeutic and influence behaviour, it must be paired with an appropriate social context2–6”

    From Refining oxytocin therapy for autism: context is key (2022) · cites this paper as [4]

  • Oxytocin enhances social salience rather than social behaviour.

    “oxytocin enhances social salience rather than social behaviour”

    From Refining oxytocin therapy for autism: context is key (2022) · cites this paper as [4]

  • Even in a therapeutic context, intranasal oxytocin is a suboptimal method for enhancing oxytocin signalling.

    “Even in a therapeutic context, intranasal oxytocin is a suboptimal method for enhancing oxytocin signalling.”

    From Refining oxytocin therapy for autism: context is key (2022) · cites this paper as [4]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [11]Skuse DH Proc. Natl. Acad. Sci. U.S.A 2014 111 1987
  2. [12]Parker KJ Proc. Natl. Acad. Sci. U.S.A 2014 111 12258

Cited by

Sorted by citations

Authors
Young, L. J., & Barrett, C. E.
Affiliations
Emory University (US)
Venue
Science
Published
2015-02-20
Volume
347
Issue
6224
Pages
825-826
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W1974789834
Cited by
200
References
15
Citations by year
2026: 4 · 2025: 7 · 2024: 8 · 2023: 9 · 2022: 16 · 2021: 22 · 2020: 16 · 2019: 10 · 2018: 31 · 2017: 25 · 2016: 30 · 2015: 22
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Mental Health (R01MH096983, P50MH100023)
  • National Institute of Neurological Disorders and Stroke (T32NS096050)
  • National Center for Research Resources (P51RR000165)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
oxytocin, autism spectrum disorder, oxytocin therapy, social cognition, social behavior
MeSH terms
Administration, Intranasal, Autistic Disorder, Clinical Trials as Topic, Cognition, Empathy, gamma-Aminobutyric Acid, Humans, Hypothalamus, Oxytocin, Social Behavior, Receptor, Melanocortin, Type 4, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review